Table 2 Characteristics of literature screened for inclusion or exclusion
From: Governance and pharmacovigilance in Brazil: a scoping review
Published literature on pharmacovigilance and regulatory governance [n = 128] | |||
|---|---|---|---|
Type | Topic | Subject | n |
A | ADR studies: | A1: Specific drug(s) [43] | 65 |
Prevalence and Characterization of ADRs | A2: Vaccines, herbals, phytopharmaceuticals, nutraceuticals, Over-the Counter [22] | ||
B | Theoretical papers (Not Brazil specific) | B1: ADR reporting [3] | 14 |
B2: Risk communication [1] | |||
B3: Regulatory harmonization [1] | |||
B4: Global actors’ norms or Global governance [6] | |||
B:5 Pharmacovigilance regulatory authority Latin America [3] | |||
C | Pharmacovigilance practices in Brazil | C1: Industry implementation of pharmacovigilance [2] | 35 |
C2: Analysis of pharmacovigilance centres, sentinel hospitals & notifying pharmacy ADR reports [9] | |||
C3: Pharmacovigilance Systems, regulations, or policies [20] | |||
C4: ADR prevention interventions [4] | |||
D | Regulatory governance, pharmacogovernance and pharmacovigilance | D1: Transparency and/or Accountability [5] | 14 |
D2: Global actors and Transparency and/or Accountability [3] | |||
D3: Regulation, Policy and Law [6] | |||